AIM
MED icon

Aigen Investment Management’s Medifast MED Stock Holding History

Aigen Investment Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103K Buy
+10,143
New +$109K 0.03% 461
2024
Q1 		– Sell
-3,700
Closed -$249K – 888
2023
Q4 		$249K Buy
3,700
+199
+6% +$13.9K 0.04% 567
2023
Q3 		$262K Sell
3,501
-3,768
-52% -$334K 0.05% 571
2023
Q2 		$670K Buy
+7,269
New +$647K 0.1% 282
2022
Q3 		– Sell
-1,716
Closed -$310K – 685
2022
Q2 		$310K Sell
1,716
-819
-32% -$147K 0.05% 390
2022
Q1 		$433K Buy
+2,535
New +$478K 0.07% 303
2021
Q4 		– Sell
-1,241
Closed -$239K – 1122
2021
Q3 		$239K Buy
+1,241
New +$305K 0.05% 385
2020
Q1 		– Sell
-2,416
Closed -$265K – 1440
2019
Q4 		$265K Buy
+2,416
New +$234K 0.04% 474

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $48.2B AUM 24.23% 1-Year Est. Return